These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 37112909)

  • 21. mRNA vaccines for COVID-19 are safe and clinically effective in patients with cardiac amyloidosis.
    Barzen G; Rieber F; Stangl K; Hahn K; Spethmann S
    Vaccine; 2024 Feb; 42(4):723-726. PubMed ID: 38158299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac MRI Findings of Myocarditis After COVID-19 mRNA Vaccination in Adolescents.
    Chelala L; Jeudy J; Hossain R; Rosenthal G; Pietris N; White CS
    AJR Am J Roentgenol; 2022 Apr; 218(4):651-657. PubMed ID: 34704459
    [No Abstract]   [Full Text] [Related]  

  • 23. Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination.
    Maeda M; Isawa T; Tada N
    Circ J; 2022 Mar; 86(4):724. PubMed ID: 34866122
    [No Abstract]   [Full Text] [Related]  

  • 24. Post-vaccine COVID-19 acute myocarditis: case reports and literature review.
    Bouchaala A; Nguadi J; Benhlima A; Arfaoui M; Elhamzaoui H; Alilou M
    Pan Afr Med J; 2023; 44():192. PubMed ID: 37484597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myocarditis post-COVID-19 vaccination.
    Bansal M; Mehta A; Pandey M
    Postgrad Med J; 2023 Sep; 99(1176):1076-1079. PubMed ID: 37334983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pericarditis and myocarditis after COVID-19 mRNA vaccination in a nationwide setting.
    Yap J; Tham MY; Poh J; Toh D; Chan CL; Lim TW; Lim SL; Chia YW; Lim YT; Choo J; Ding ZP; Foo LL; Kuo S; Lau YH; Lee A; Yeo KK
    Ann Acad Med Singap; 2022 Feb; 51(2):96-100. PubMed ID: 35224605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac complications following mRNA COVID-19 vaccines: A systematic review of case reports and case series.
    Fazlollahi A; Zahmatyar M; Noori M; Nejadghaderi SA; Sullman MJM; Shekarriz-Foumani R; Kolahi AA; Singh K; Safiri S
    Rev Med Virol; 2022 Jul; 32(4):e2318. PubMed ID: 34921468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study.
    Husby A; Hansen JV; Fosbøl E; Thiesson EM; Madsen M; Thomsen RW; Sørensen HT; Andersen M; Wohlfahrt J; Gislason G; Torp-Pedersen C; Køber L; Hviid A
    BMJ; 2021 Dec; 375():e068665. PubMed ID: 34916207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination.
    Kim HW; Jenista ER; Wendell DC; Azevedo CF; Campbell MJ; Darty SN; Parker MA; Kim RJ
    JAMA Cardiol; 2021 Oct; 6(10):1196-1201. PubMed ID: 34185046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Myocarditis and pericarditis following mRNA COVID-19 vaccination. Expert opinion of the Italian Society of Cardiology].
    Sinagra G; Porcari A; Merlo M; Barillà F; Basso C; Ciccone MM; Curcio A; Mancone M; Mercuro G; Muscoli S; Nodari S; Pedrinelli R; Spaccarotella C; Filardi PP; Indolfi C
    G Ital Cardiol (Rome); 2021 Nov; 22(11):894-899. PubMed ID: 34709228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature.
    Lane S; Yeomans A; Shakir S
    BMJ Open; 2022 May; 12(5):e059223. PubMed ID: 35613761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute cardiac side effects after COVID-19 mRNA vaccination: a case series.
    Freise NF; Kivel M; Grebe O; Meyer C; Wafaisade B; Peiper M; Zeus T; Schmidt J; Neuwahl J; Jazmati D; Luedde T; Bölke E; Feldt T; Jensen BEO; Bode J; Keitel V; Haussmann J; Tamaskovics B; Budach W; Fischer JC; Knoefel WT; Schneider M; Gerber PA; Pedoto A; Häussinger D; van Griensven M; Rezazadeh A; Flaig Y; Kirchner J; Antoch G; Schelzig H; Matuschek C
    Eur J Med Res; 2022 Jun; 27(1):80. PubMed ID: 35655235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute Myocarditis in a Patient Following mRNA-1273 SARS-CoV-2 Vaccination.
    Kawakami T; Yahagi K; Sekiguchi M; Ishizawa T; Nonaka H; Setoguchi N; Watanabe Y; Nakase M; Horiuchi Y; Asami M; Yuzawa H; Komiyama K; Tanaka J; Aoki J; Tanabe K
    Intern Med; 2022 May; 61(9):1371-1374. PubMed ID: 35249920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two Cases of Acute Myocarditis in Young Male Adults After mRNA Vaccines Against COVID-19: Similarities and Differences.
    Sdogkos E; Sideri A; Kasmeridis C; Konstantinou T; Vogiatzis I
    Med Arch; 2022 Jun; 76(3):215-220. PubMed ID: 36200112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocarditis Following Coronavirus Disease 2019 mRNA Vaccine: A Case Series and Incidence Rate Determination.
    Perez Y; Levy ER; Joshi AY; Virk A; Rodriguez-Porcel M; Johnson M; Roellinger D; Vanichkachorn G; Charles Huskins W; Swift MD
    Clin Infect Dis; 2022 Aug; 75(1):e749-e754. PubMed ID: 34734240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial.
    Chen GL; Li XF; Dai XH; Li N; Cheng ML; Huang Z; Shen J; Ge YH; Shen ZW; Deng YQ; Yang SY; Zhao H; Zhang NN; Zhang YF; Wei L; Wu KQ; Zhu MF; Peng CG; Jiang Q; Cao SC; Li YH; Zhao DH; Wu XH; Ni L; Shen HH; Dong C; Ying B; Sheng GP; Qin CF; Gao HN; Li LJ
    Lancet Microbe; 2022 Mar; 3(3):e193-e202. PubMed ID: 35098177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.
    Gargano JW; Wallace M; Hadler SC; Langley G; Su JR; Oster ME; Broder KR; Gee J; Weintraub E; Shimabukuro T; Scobie HM; Moulia D; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(27):977-982. PubMed ID: 34237049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocarditis following COVID-19 vaccination: incidence, mechanisms, and clinical considerations.
    Power JR; Keyt LK; Adler ED
    Expert Rev Cardiovasc Ther; 2022 Apr; 20(4):241-251. PubMed ID: 35414326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paving the Way Towards Precision Vaccinology: The Paradigm of Myocarditis After Coronavirus Disease 2019 (COVID-19) Vaccination.
    Lagousi T; Papadatou I; Strempas P; Chatzikalil E; Spoulou V
    Clin Infect Dis; 2022 Aug; 75(Suppl 1):S18-S23. PubMed ID: 35607748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.